Experimental evidence supports this mechanism: in models of left ventricular pressure overload [33,34] and diabetic cardiomyopathy [35], genetic deletion of IL-6 significantly alleviates myocardial fibrosis and associated dysfunction, whereas IL-6 overexpression exacerbates the fibrotic phenotype. This evidence concerns the gene IL6 and Myocardial fibrosis.